|
| ID |
DDInter1038 |
| Drug Type |
small molecule |
| Molecular Formula |
C17H14Brn3O2S |
| Molecular Weight |
404.288
|
| Description |
Lesinurad is a uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy.
|
| ATC Classification |
M04AB05
|
| IUPAC Name |
2-{[5-Bromo-4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazol-3-Yl]Sulfanyl}Acetic Acid |
| InChI |
Inchi=1S/C17H14Brn3O2S/C18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/H1-4,7-8,10H,5-6,9H2,(H,22,23) |
| InChI Key |
FGQFOYHRJSUHMR-UHFFFAOYSA-N |
| Canonical SMILES |
OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|